Application of Genomic Testing in Precision Oncology
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Methods and Technologies Development".
Deadline for manuscript submissions: 30 September 2024 | Viewed by 114
Special Issue Editor
Special Issue Information
Dear Colleagues,
Genomics has emerged and become one of the major components of precision oncology in the last decade. DNA, being a component of higher stability among the nucleotides, has become a component of preliminary importance. With transcriptomics and proteomics still in the emerging phase, genomics has gained more momentum in recent times. Besides just cancer diagnosis and therapy, genomics is also very functional in disease risk prediction, pharmacological response prediction, and drug toxicity and response predictions, including nutrigenomics. Cancer is not just a lonely disease but a multifactorial complexity which involves nucleotide omics, nutritional profiling, pharmacogenomic factors, etc., to combinedly function for overall prediction.
Altogether, these individual attributes work together to enable precision oncology. Since precision oncology is involved in achieving personalized disease intervention approaches, considering complex parameters is important. Above all, determining the clinical importance of these findings to enable precise diagnoses is important to progress.
Papers related to these areas are welcome to be submitted for this Special Issue, whether they are about personalized therapies, therapy response monitoring, treatment toxicities, immune-related adverse events, supportive care, palliative care or diagnostics, etc.
Dr. Gowhar Shafi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- precision oncology
- genomics
- immunotherapy
- targeted therapy
- AI in precision oncology
- prognosis
- predictive
